PET/CT Clinical Trials

31 recruitingLast updated: June 17, 2026

There are 31 actively recruiting pet/ct clinical trials across 8 countries. Studies span Not Applicable, Early Phase 1, Phase 2, Phase 3. Top locations include Xiamen, Fujian, China, Wuhan, Hubei, China, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


PET/CT Trials at a Glance

31 actively recruiting trials for pet/ct are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Xiamen, Wuhan, and Beijing. Lead sponsors running pet/ct studies include The First Affiliated Hospital of Xiamen University, Zhongnan Hospital, and Anhui Provincial Hospital.

Browse pet/ct trials by phase

Treatments under study

About PET/CT Clinical Trials

Looking for clinical trials for PET/CT? There are currently 25 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new PET/CT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about PET/CT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Phase 2

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations

PET/CT ImagingPilot StudyHost Disease Manifestation
M.D. Anderson Cancer Center16 enrolled1 locationNCT07325253
Recruiting

New AI-based Technologies in Nuclear Medicine

Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Azienda USL Reggio Emilia - IRCCS1,500 enrolled1 locationNCT07174089
Recruiting

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Non-small Cell Lung CancerPET/CTMalignant Neoplasm+1 more
Peking University People's Hospital80 enrolled1 locationNCT07487883
Recruiting

FAP-targeted PET/NIR in Lung Malignant Tumors

Neoadjuvant TherapyNon-small Cell Lung CancerPET/CT
Peking University People's Hospital200 enrolled1 locationNCT07498933
Recruiting
Not Applicable

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

PET/CTNeuroendocrine CancerDLL3-expressing Tumors
The First Affiliated Hospital of Xiamen University60 enrolled1 locationNCT07458906
Recruiting

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer

Breast CancerPET/CT
Kunwei Shen150 enrolled1 locationNCT06559371
Recruiting

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

Lung CancerPET/CT
Shanghai Pulmonary Hospital, Shanghai, China10,000 enrolled5 locationsNCT07243873
Recruiting
Not Applicable

68Ga-XACP3 PET/CT in Prostate Cancer

Prostate CancerPET/CTACP3
The First Affiliated Hospital of Xiamen University60 enrolled1 locationNCT07242014
Recruiting

PET/CT for Trop2 ADC Response Evaluation NSCLC

NSCLCTrop2PET/CT
The First Affiliated Hospital of Xiamen University50 enrolled1 locationNCT07151898
Recruiting
Phase 2Phase 3

[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer

Gastric CancerLocally Advanced Gastric AdenocarcinomaPET/CT+1 more
Leiden University Medical Center250 enrolled10 locationsNCT07018661
Recruiting

PET/CT for Trop2 ADC Response Evaluation Cancers

Breast CancerTrop2PET/CT
The First Affiliated Hospital of Xiamen University50 enrolled1 locationNCT07046689
Recruiting

68Ga-MY6349 PET/CT in Solid Tumors

Solid TumorTrop2PET/CT
The First Affiliated Hospital of Xiamen University300 enrolled1 locationNCT07046702
Recruiting
Not Applicable

Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia

Cold ExposureBrown Adipose Tissue18F-FDG PET/CT
University of Edinburgh12 enrolled1 locationNCT07048405
Recruiting
Not Applicable

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

PET/CTHematological MalignancyCXCR4
Zhongnan Hospital300 enrolled1 locationNCT05255926
Recruiting
Not Applicable

68Ga-FAPI PET/CT in Malignant Tumors

PET/CTMalignant NeoplasmFibroblast Activation Protein Inhibitor
Zhongnan Hospital500 enrolled1 locationNCT05034146
Recruiting

Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

PET/CTOral CancerFAPI
Zhongnan Hospital100 enrolled1 locationNCT05030597
Recruiting

Integrin αvβ6-targeted PET in Malignant Tumors

Breast Cancer MetastaticNon-small Cell Lung CancerPET/CT+1 more
Zhongnan Hospital200 enrolled1 locationNCT05835570
Recruiting
Not Applicable

PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell CarcinomaPET/CT
Rigshospitalet, Denmark600 enrolled1 locationNCT05707078
Recruiting
Not Applicable

Study on c-Met Targeted PET/CT Imaging in NSCLC

NSCLCPET/CT Imaging
Xilin Sun88 enrolled1 locationNCT06911697
Recruiting
Phase 2

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Cervical CancerPET/CTRadiotherapy+2 more
Peking Union Medical College Hospital51 enrolled1 locationNCT06353061